Starling Oncology (STLNW) Gains from Investment Securities (2020 - 2026)
Starling Oncology's (STLNW) quarterly Gains from Investment Securities came in at -$6000.0 in Q2 2026, down 111.32% on a YoY basis from $53000.0 in Q2 2025, and up 96.43% quarter-over-quarter from -$168000.0 in Q1 2026.
Powered by 
Analysis
Starling Oncology (STLNW) Gains from Investment Securities (2020 - 2026) Analysis & Trends
Starling Oncology (STLNW) has reported Gains from Investment Securities for 7 consecutive years, with -$6000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Gains from Investment Securities fell 111.32% year-over-year to -$6000.0; the trailing twelve-month figure through Jun 2026 stood at -$23000.0 (down 179.31% YoY), and the FY2025 full-year result was $247000.0, up 139.9% from the prior year.
- Gains from Investment Securities advanced to -$6000.0 in Q2 2026 per STLNW's latest filing, from -$168000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $203000.0 in Q3 2023 and bottomed at -$39.4 million in Q1 2022.
- Historically, Gains from Investment Securities has averaged -$3.6 million across 5 years, with a median of -$47000.0 in 2024.
- The sharpest annual moves came in 2025 and 2026: Gains from Investment Securities surged 850.0% in 2025, then slumped 490.7% in 2026.
- Over 5 years, Gains from Investment Securities stood at -$5.4 million in 2022, then soared by 99.8% to -$11000.0 in 2023, then plunged by 327.27% to -$47000.0 in 2024, then jumped by 102.13% to $1000.0 in 2025, then sank by 700.0% to -$6000.0 in 2026.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered -$6000.0, -$168000.0, and $1000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Davita | 11.90 Bn | 11.21 Bn | 1.16 Bn |
| 2 | RadNet | 5.50 Bn | 4.77 Bn | 88.08 Mn |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn |
| 4 | Concentra Group Holdings Parent | 4.28 Bn | 4.12 Bn | 192.10 Mn |
| 5 | Privia Health | 2.57 Bn | 2.16 Bn | - |
| 6 | Pediatrix Medical | 2.15 Bn | 1.75 Bn | - |
| 7 | Progyny | 2.11 Bn | 1.87 Bn | 89.30 Mn |
| 8 | Surgery Partners | 1.85 Bn | 1.63 Bn | 622.10 Mn |
| 9 | U S Physical Therapy | 1.18 Bn | 1.15 Bn | 41.94 Mn |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6,000.00 |
| Mar 31, 2026 | -168,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | 150,000.00 |
| Jun 30, 2025 | 53,000.00 |
| Mar 31, 2025 | 43,000.00 |
| Dec 31, 2024 | -47,000.00 |
| Sep 30, 2024 | -20,000.00 |
| Jun 30, 2024 | -552,000.00 |
| Dec 31, 2023 | -11,000.00 |
| Sep 30, 2023 | 203,000.00 |
| Jun 30, 2023 | -118,000.00 |
| Mar 31, 2023 | -752,000.00 |
| Dec 31, 2022 | -5.39 Mn |
| Sep 30, 2022 | -3.58 Mn |
| Jun 30, 2022 | -10.80 Mn |
| Mar 31, 2022 | -39.44 Mn |
| Dec 31, 2021 | -24.89 Mn |
| Dec 31, 2020 | -5.20 Mn |
| Sep 30, 2020 | 2.30 Mn |